Regulatory Affairs Intern

Dental leaders call for prevention to move from 'afterthought' to frontline care at Smile Month 50th anniversary panel. Dental leaders, educators and future members of the profession have called for a stronger focus on evidence-based prevention, clearer patient communication and greater collaboration across the oral healthcare workforce during a special panel event marking 50 years of Smile Month. Hosted by the Oral Health Foundation, the discussion brought together voices from across dentistry to reflect on the progress made in oral health over the past five decades - and the challenges still facing the profession. A recurring theme throughout the panel was the need to move prevention from the margins of dentistry to the centre of patient care. Speakers highlighted the importance of giving both patients and dental professionals clearer, more consistent guidance on evidence-based prevention and daily oral health routines. Supporting this ambition, the Oral Health Foundation is partnering with Kenvue on behalf of Listerine to help turn the latest clinical consensus on dental plaque biofilm management into practical advice for both patients and the wider dental team. The partnership will develop new patient education materials and chairside support tools for the dental team. The aim is to help professionals communicate prevention advice more clearly and consistently, particularly around daily oral hygiene routines and the role of adjunctive plaque control. The initiative follows a landmark professional consensus supported by the Oral Health Foundation, the BSP, BSDHT and BADT, which reinforced the importance of evidence-based prevention strategies and clearer public understanding of oral disease prevention. Speaking at the panel event, Dr Fiona Sandom, a dental educator at Health Education and Improvement Wales and former President of the British Association of Dental Therapists, warned that prevention is still not receiving the attention it deserves within the system. Dr Sandom said: "Students feel the system is reactive and that prevention is almost like an afterthought rather than being at the forefront. "We talk about prevention, but we do not give it a consistent approach, and it is still secondary." The panel also highlighted the need for the profession to improve how it communicates prevention advice to patients and communities, particularly as oral health inequalities continue to widen. Professor Iain Chapple, Professor of Periodontology at the University of Birmingham, stressed the importance of translating evidence into clear and practical guidance for patients. Professor Chapple said: "The biggest behaviour change challenge Dentalhealth has is not in its patients. It is in its own behaviour. "We need clarity and a very clear message that people do not feel is going to change every five minutes." The discussion closely reflected a growing movement across dentistry towards more consistent, evidence-based prevention messaging, including greater awareness of the role of adjunctive plaque control in daily oral hygiene routines. Professor Chapple added: "Mechanical plaque removal with fluoride toothpaste remains the foundation, but in some cases chemical agents in toothpaste and mouthwash absolutely have a role to play." The event also explored the future role of the wider dental team in delivering prevention and improving patient access to care. Preetee Hylton, former President of the British Association of Dental Nurses, said the future of dentistry must be more collaborative and prevention-led. Ms Hylton said: "Dentalhealth all contribute as a team to prevention, communication and patient safety. "We have to start right at the beginning - educating mothers, going into communities and intervening earlier, not simply delivering restorative dentistry once disease has developed." The panel repeatedly returned to the importance of taking prevention beyond the surgery and into communities where oral disease and inequalities remain highest. Dr Sandom added: "We need to take prevention out to the community rather than making patients come to us for prevention." The event also addressed the growing role of industry collaboration in supporting oral health education and improving public understanding of evidence-based prevention. "Our industry partners have wonderful ways of improving health literacy in the community," said Professor Chapple. "Whether it's Haleon or Kenvue, we have the same objective - to improve oral health." The discussion comes as the Oral Health Foundation continues its work with partners across dentistry and industry to help improve patient understanding of evidence-based prevention strategies and support more consistent oral health messaging across the profession. Smile Month, now celebrating its 50th anniversary, remains one of the UK's longest-running and most recognised oral health campaigns.

Why does the $48.7 billion Kenvue merger matter for custom blend foundation? Quick Answer: The Kimberly-Clark acquisition of Kenvue creates a consumer health conglomerate with more than $32 billion in annual revenue and 10 billion-dollar brands, concentrating manufacturing scale under a single entity. For brands exploring custom blend foundation and personalized formulation, this consolidation increases the strategic value of independent infrastructure partners that can offer neutrality, speed, and specialized capability without the channel conflicts inherent in conglomerate-owned facilities. Kimberly-Clark's $48.7 billion acquisition of Kenvue, approved by shareholders in January 2026 and expected to close in the second half of the year, represents the largest consolidation in consumer health and beauty in recent years. Kenvue's Skin Health and Beauty division reported 8.4% net sales growth to $1 billion in Q1 2026, validating the category's resilience. The deal follows a broader pattern of supply-side consolidation across beauty manufacturing, even as new independent facilities like Beauty Chain Capital's Reno platform enter the market. For brands evaluating custom blend foundation infrastructure, the merger underscores both the competitive pressure of scale and the emerging opportunity for neutral manufacturing partnerships. May 24, 2026 Key takeaways. Kimberly-Clark's acquisition of Kenvue is valued at approximately $48.7 billion, creating a combined entity with more than $32 billion in annual revenue. Kenvue's Skin Health and Beauty division grew net sales by 8.4% to $1 billion in Q1 2026, with 5% organic growth. The combined company will control 10 billion-dollar brands and expects $2.1 billion in annual run-rate synergies. Supply-side consolidation in 2025 included major deals such as Persan's acquisition of Mibelle Group and kdc/one's combination with Maesa. Independent U.S. manufacturing platforms are launching to counterbalance conglomerate scale, with Beauty Chain Capital opening a 100,000-plus square foot facility in Reno, Nevada. Custom blend foundation and personalized formulation infrastructure gain strategic relevance as brands seek manufacturing neutrality outside conglomerate-owned networks. The Kimberly-Clark Kenvue deal and custom blend foundation scale. According to Kenvue shareholder filings, both companies overwhelmingly approved the $48.7 billion transaction at their respective special meetings in January 2026. The deal is expected to close in the second half of 2026, subject to regulatory approvals and customary closing conditions. Per Kirkland & Ellis advisory disclosures, Kenvue shareholders will receive $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each Kenvue share held. The total consideration of $21.01 per share represents an acquisition multiple of approximately 14.3x Kenvue's last-twelve-month adjusted EBITDA. FiercePharma analysis notes that the combined company will control 10 billion-dollar brands including Huggies, Kleenex, Neutrogena, Aveeno, and OGX. Dakota found that the valuation represents a roughly 46% premium to Kenvue's prior closing price. The combined entity is expected to generate roughly $32 billion in annual revenue and $7 billion in adjusted EBITDA, with projected annual run-rate synergies of $2.1 billion by 2030. For brands developing custom blend foundation capabilities, this scale creates a formidable competitor for shelf space and retail negotiation leverage, while also raising questions about access to impartial manufacturing partners. Personalized foundation 2026: why Skin Health and Beauty led Kenvue's growth. Cosmetics Business reports that Kenvue's Skin Health and Beauty division delivered the strongest performance in Q1 2026, with net sales increasing 8.4% to $1 billion compared with the prior-year quarter. Organic sales in the segment rose 5%, driven by volume growth of 4.2% and favorable value realization across EMEA, Latin America, and Asia Pacific. Data from Global Cosmetics News shows that total company net sales increased 4.5% to $3.9 billion in the quarter, with gross profit margin expanding to 58.9% from 58.0% in the prior-year period. The beauty division's outperformance was fueled by innovation launches including Neutrogena Sun Care expansion in select EMEA markets and the introduction of OGX Pro Growth in North America and EMEA. This growth trajectory explains why Kimberly-Clark pursued the acquisition at a premium valuation. Personalized foundation 2026 and broader skin health categories are delivering durable, high-margin revenue that offsets cyclicality in paper-based commodities. However, as conglomerates absorb successful beauty brands into vertically integrated portfolios, mid-market and emerging brands may find it harder to secure unbiased manufacturing capacity for specialized or on-demand formulation. Smart mirror beauty technology and the consolidation ripple effect. Global Cosmetics News 2025 supply-side review found that consolidation across beauty manufacturing accelerated last year. Persan's agreement with Migros to acquire Mibelle Group brought private label, contract manufacturing, and formulation under one roof in a combined business expected to generate around €1 billion in turnover. Similarly, kdc/one's combination with Maesa blended advanced manufacturing and packaging expertise with brand storytelling capabilities. According to Beauty Packaging coverage, Beauty Chain Capital launched a 100,000-plus square foot manufacturing facility in Reno, Nevada in April 2026. The platform offers full in-house formulation across liquids and powders, large-scale compounding, high-speed filling, and turnkey services including component sourcing and regulatory compliance. Beauty Chain Capital co-founder Derek Harvey stated in the Beauty Packaging report that brands have relied on overseas partners for innovation too long and that the model is changing. This dual dynamic, mega-mergers alongside independent domestic investment, defines the current manufacturing landscape. Smart mirror beauty technology and AI-driven personalization require manufacturing partners that can execute small-batch precision and rapid formulation changes. Conglomerate-owned facilities optimized for million-unit runs of fixed SKUs may lack the flexibility or incentive to support these emerging production models. Foundation dispenser machine infrastructure in a consolidating market. The Kenvue merger validates that scale and vertical integration remain competitive advantages in beauty manufacturing. Large combined entities can squeeze supplier costs, dominate shelf negotiations, and internalize R&D. Yet this concentration also creates space for independent infrastructure providers that offer neutrality, flexibility, and specialized capability without the conflicts of interest inherent in conglomerate-owned manufacturing. Foundation dispenser machine platforms and precision blending infrastructure fall into this category. These systems require partners capable of executing micro-dosing accuracy, maintaining formulation stability across refill cycles, and adapting to real-time consumer data. When manufacturing is owned by the same conglomerates that control competing brands, independent players face both capacity constraints and information asymmetry. Brands investing in foundation dispenser machine technology need partners that can deliver precision without channel conflict. AI foundation matching generates consumer-specific shade and undertone data that must translate into precise physical formulation. In a consolidated manufacturing landscape, the brands owning the AI tools may also own the production facilities, creating potential conflicts when third-party brands need unbiased capacity. Neutral infrastructure providers that separate matching technology from manufacturing ownership reduce this risk. Brands evaluating manufacturing partnerships in a consolidating landscape should assess whether a provider can deliver speed and specialization without channel conflict. Solutions like how foundation matching reduces retail shrinkage are already being explored to bridge the gap between personalization infrastructure and retail execution. These approaches emphasize manufacturing neutrality and formulation precision as core requirements rather than afterthoughts in a market defined by consolidation.